Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) Director Melissa Starovasnik sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $51.00, for a total transaction of $51,000.00. Following the completion of the transaction, the director directly owned 25,722 shares in the

SG Americas Securities LLC lifted its holdings in Twist Bioscience Corporation (NASDAQ: TWST) by 350.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 76,484 shares of the company's stock after acquiring an additional 59,500 shares during the quarter. SG Americas Securities LLC

Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating and seven have given a buy rating to the company. The average 12 month target price

Twist Bioscience (NASDAQ: TWST - Get Free Report) and Zenas BioPharma (NASDAQ: ZBIO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability. Analyst Ratings This is a summary of current

Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Citigroup Inc. reduced its position in Twist Bioscience Corporation (NASDAQ: TWST) by 24.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,458 shares of the company's stock after selling 30,231 shares during the quarter. Citigroup Inc.

Artisan Partners Limited Partnership boosted its stake in Twist Bioscience Corporation (NASDAQ: TWST) by 26.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,410,900 shares of the company's stock after buying an additional 1,349,867 shares during the quarter. Artisan Partners

Shares of Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $52.49, but opened at $49.90. Twist Bioscience shares last traded at $49.73, with a volume of 213,406 shares. Analyst Ratings Changes A number of brokerages have issued reports on TWST. TD

Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript

Cathie Wood's ARK Invest ETFs made notable portfolio moves on Tuesday, according to a Tuesday filing with the SEC.Wood increased exposure to semiconductor firms